Sector Gamma AS’s Travere Therapeutics TVTX Stock Holding History

Sector Gamma AS’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.54M	Buy	+80,000	New	+$3.55M	0.99%	33

Other funds holding TVTX

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sector Gamma AS's TVTX Position: Q2 2026 in Review

Sector Gamma AS opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 80,000 shares worth $4.54M. The stake represents 0.99% of the portfolio and ranks #33 among its holdings.

320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

Sector Gamma AS held 80,000 shares of Travere Therapeutics worth $4.54M as of Q2 2026.
Travere Therapeutics was a new Sector Gamma AS position in Q2 2026.
Travere Therapeutics made up 0.99% of Sector Gamma AS's portfolio in Q2 2026, its #33 holding.
320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.